Breaking News

Schreiner MediPharm Introduces NFC-Labels for Self-Administered Injectables

Added smartphone verification adds an extra layer of anti-counterfeiting security and tamper evidence.

By: Rachel Klemovitch

Assistant Editor

Schreiner MediPharm, a Germany-based global provider of functional label solutions for the healthcare industry, has introduced NFC-Labels that offer an added layer of protection against counterfeiting for self-administered injectable drugs with smartphone authentication.  In addition to point-of-use verification, the NFC-Labels also enable interactive patient instruction and support. The new NFC-Labels offer digital first-opening indications. The labels wrap around part of the cap of the ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters